UBX
Unity Biotechnology
Delisted
UBX was delisted on the 8th of July, 2025.
36 hedge funds and large institutions have $6.42M invested in Unity Biotechnology in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
10% less funds holding
Funds holding: 40 → 36 (-4)
33% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 9
50% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 8
Holders
36
Holding in Top 10
3
Calls
$3.75M
Puts
$40K
Top Buyers
| 1 | +$92.9K | |
| 2 | +$46K | |
| 3 | +$41K | |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$20.9K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$13.6K |
Top Sellers
| 1 | -$54.8K | |
| 2 | -$50.9K | |
| 3 | -$46K | |
| 4 |
Morgan Stanley
New York
|
-$37.8K |
| 5 |
Prudential Financial
Newark,
New Jersey
|
-$33.6K |